Complete Inventory

← Go back

Go back

Date of filling in this questionnaire or last update: 17/01/2026

1. IDENTIFICATION & BASIC DESCRIPTION

Cohort name

ECRHS - European Community Respiratory Health Survey

Country

Algeria
Australia
Austria
Denmark
Estonia
France
Germany
Greece
Iceland
India
Ireland
Italy
Netherlands
New Zealand
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom
United States

Name

Debbie Jarvis

Institution

Imperial College, London, UK

Email

d.jarvis@imperial.ac.uk

Personal website

http://www.imperial.ac.uk/people/d.jarvis

Website

https://www.ecrhs.org/

Name of committee

Due to the muticentre structure of ECRHS multiple ethical committees involved

Or provide website

https://www.ecrhs.org/

Contact Principal Investigator (name)

Debbie Jarvis

Is this cohort part of a consortium? (name consortium)

The European Occupational Exposome and Health Cohort Consortium

Participation in pooled analyses

The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort

To provide information about (change in) prevalence and incidence of respiratory disease and allergy, and to identify risk factors and beneficial factors for both development and prognosis of respiratory disease and allergy

Study design (please select as many as appropriate)

Prospective cohort

Source population (please select as many as appropriate)

General population: International

Comparators (please select as many as appropriate)

Internal study population

Enrollment

Ongoing

Age range at entry (main cohort)

Minimum	Maximum	Mean
20	44

Men at enrollment

5,000

Women at enrollment

5,000

Children (<18 years) at enrollment

Men at last follow-up

3,400

Women at last follow-up

3,600

Children (<18 years) at last follow-up

Participation rate at enrollment (if known)

Comments

Overall 78%. Range 54–100, 48 centres.

2. OUTCOME FOLLOW-UP

Type of data for outcome follow-up (please select as many as appropriate)

Active (contact with participants)

Active (contact with participants) (specify)

For a subgroup of the population clinical investigations with a focus on lung disease and allergy were performed at baseline and subsequently at two follow-ups

First follow-up period (provide year)

2026

Participation at last follow-up (if known)

Comments

Please see flow chart in: Jarvis D. et al Prevalence of asthma-like symptoms with ageing. Thorax. 2018 Jan;73(1):37-48.

3. OCCUPATIONAL EXPOSURES

Source of exposure data collected (please select as many as appropriate)

Questionnaire, Personal (Self-reporting or interview)
Questionnaire, Personal (Occupational/industry modules)
Environmental samples

Occupational history/time frame

Lifetime

Occupational coding performed

Yes

Occupation (specify coding system used)

ISCO88

Types of exposure measurements

Biomarkers (see also section 5)
Personal external sampling

Methods for exposure assessment (please select as many as appropriate)

Expert assessment
Job Exposure Matrix
Measurements (external sampling, biomarkers)
Self-report

ALOHA+ JEM

Please insert reference/further information

Lytras T, et al . Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey. Thorax. 2018 Nov;73(11):1008-1015.

Asthma JEM

Please insert reference/further information

Pape et al. Parental occupational exposure pre- and post-conception and development of asthma in offspring. Int J Epidemiol. 2020 Jul 14:dyaa085. doi: 10.1093/ije/dyaa085. Epub ahead of print.

DOM-JEM

FIN-JEM

Main categories

Dusts and fibres
Pesticides
Other chemicals
Ergonomics, physical workload, and injury related
Psychosocial domains

Dusts and fibres | Fibres

Other (specify)

Dusts and fibres | Fibres | Specify: Other